Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DC-PNAT and Gemcitabine in Advanced Biliary Tract Malignant Tumor
NCT02632019Phase 2Unknown
- Sponsor
- Naval Medical University
- Start
- Sep 2015
- Primary completion
- Mar 2017
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of DC-PNAT in biliary tract cancer (BTC), sponsored by Naval Medical University. Status: unknown.
02
Drugs
DC-PNAT
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT02632019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02632019.